Nuvation Bio Inc
(NUVB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -567,939 | -75,802 | -104,199 | -86,848 | -41,659 |
| Depreciation Amortization | 683 | 222 | 199 | 184 | 103 |
| Accounts receivable | -12,722 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -1,654 | 70 | -1,786 | 1,861 | 34 |
| Other Working Capital | -12,507 | 540 | -3,447 | 4,793 | 2,110 |
| Other Operating Activity | 463,726 | 6,971 | 13,125 | 11,820 | 2,883 |
| Operating Cash Flow | $-130,413 | $-67,999 | $-96,108 | $-68,190 | $-36,529 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 110,437 | 8,976 | 63,814 | -454,387 | -72,683 |
| PPE Investments | -162 | -55 | -357 | -282 | -145 |
| Net Acquisitions | 19,862 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | N/A | N/A | N/A | N/A | 2,508 |
| Other Investing Activity | -7,434 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $122,703 | $8,921 | $63,457 | $-454,669 | $-70,320 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 12,609 | N/A | N/A | N/A | N/A |
| Debt Repayment | -17,163 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 4,885 | 628 | 1,327 | 758 | 0 |
| Other Financing Activity | 0 | 0 | 0 | 624,769 | 133,135 |
| Financing Cash Flow | $331 | $628 | $1,327 | $625,527 | $133,135 |
| Exchange Rate Effect | 453 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 42,649 | 101,099 | 132,423 | 29,755 | 3,469 |
| End Cash Position | 35,723 | 42,649 | 101,099 | 132,423 | 29,755 |
| Net Cash Flow | $-6,926 | $-58,450 | $-31,324 | $102,668 | $26,286 |
| Free Cash Flow | |||||
| Operating Cash Flow | -130,413 | -67,999 | -96,108 | -68,190 | -36,529 |
| Capital Expenditure | -162 | -69 | -370 | -282 | -145 |
| Free Cash Flow | -130,575 | -68,068 | -96,478 | -68,472 | -36,674 |